The Partnership between the FNIH and Bioibérica Farma will Boost Research on Osteoarthritis BiomarkersTheir new project focus on the research and validation of imaging and biochemical biomarkers used to diagnose knee osteoarthritis (OA) prior to the development of symptoms, to identify patient’s profiles, and to predict disease progression.
Biomarkers could be used to measure the efficacy of treatments, thus enabling the National Health System to save money.
The Foundation of the National Institutes of Health guarantees that the aim of this partnership is the improvement of the quality of life of OA patients by means of early diagnosis and personalized treatment.
